285 related articles for article (PubMed ID: 28382968)
21. Remarkable motor recovery after riboflavin therapy in adult-onset Brown-Vialetto-Van Laere syndrome.
Bashford JA; Chowdhury FA; Shaw CE
Pract Neurol; 2017 Jan; 17(1):53-56. PubMed ID: 27777325
[TBL] [Abstract][Full Text] [Related]
22. Brown-Vialetto-Van Laere syndrome: A rare case report of MND mimic.
Kranthi P; Garuda BR; Gopi S; Kumar TS
Neurol India; 2020; 68(5):1217-1219. PubMed ID: 33109881
[TBL] [Abstract][Full Text] [Related]
23. Dramatic Improvement of a Rare Syndrome With High Dose Riboflavin Treatment.
Forman EB; Foley AR; King MD
Pediatr Neurol; 2018 Sep; 86():77-78. PubMed ID: 30072240
[No Abstract] [Full Text] [Related]
24. Antioxidant Amelioration of Riboflavin Transporter Deficiency in Motoneurons Derived from Patient-Specific Induced Pluripotent Stem Cells.
Marioli C; Magliocca V; Petrini S; Niceforo A; Borghi R; Petrillo S; La Rosa P; Colasuonno F; Persichini T; Piemonte F; Massey K; Tartaglia M; Moreno S; Bertini E; Compagnucci C
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036493
[TBL] [Abstract][Full Text] [Related]
25. Global transcriptome profile of the developmental principles of in vitro iPSC-to-motor neuron differentiation.
Solomon E; Davis-Anderson K; Hovde B; Micheva-Viteva S; Harris JF; Twary S; Iyer R
BMC Mol Cell Biol; 2021 Feb; 22(1):13. PubMed ID: 33602141
[TBL] [Abstract][Full Text] [Related]
26. A Case of Brown-Vialetto-Van Laere Syndrome Due To a Novel Mutation in
Thulasi V; Veerapandiyan A; Pletcher BA; Tong CM; Ming X
Child Neurol Open; 2017; 4():2329048X17725610. PubMed ID: 28856173
[TBL] [Abstract][Full Text] [Related]
27. The audiovestibular profile of Brown-Vialetto-Van Laere syndrome.
Omar R; Rajput K; Sirimanna T; Rajput S; Pagarkar W
J Laryngol Otol; 2021 Nov; 135(11):1000-1009. PubMed ID: 34496984
[TBL] [Abstract][Full Text] [Related]
28. Thirteen-month-old girl with hyporegenerative macrocytic anemia due to Brown-Vialetto-Van Laere syndrome 2.
Naami N; Borkhardt A; Yoshimi A; Grinstein L; Escherich G
Am J Hematol; 2022 Nov; 97(11):1495-1496. PubMed ID: 35441393
[TBL] [Abstract][Full Text] [Related]
29. Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
Gorcenco S; Vaz FM; Tracewska-Siemiatkowska A; Tranebjærg L; Cremers FPM; Ygland E; Kicsi J; Rendtorff ND; Möller C; Kjellström U; Andréasson S; Puschmann A
Parkinsonism Relat Disord; 2019 Apr; 61():245-247. PubMed ID: 30343981
[No Abstract] [Full Text] [Related]
30. Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.
Johnson JO; Gibbs JR; Megarbane A; Urtizberea JA; Hernandez DG; Foley AR; Arepalli S; Pandraud A; Simón-Sánchez J; Clayton P; Reilly MM; Muntoni F; Abramzon Y; Houlden H; Singleton AB
Brain; 2012 Sep; 135(Pt 9):2875-82. PubMed ID: 22740598
[TBL] [Abstract][Full Text] [Related]
31. Brown-Vialetto-Van Laere syndrome: a novel diagnosis to a common presentation.
Abbas Q; Jafri SK; Ishaque S; Rahman AJ
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29950502
[TBL] [Abstract][Full Text] [Related]
32. Child Neurology: Brown-Vialetto-Van Laere syndrome: Dramatic visual recovery after delayed riboflavin therapy.
Bamaga AK; Maamari RN; Culican SM; Shinawi M; Golumbek PT
Neurology; 2018 Nov; 91(20):938-941. PubMed ID: 30420458
[No Abstract] [Full Text] [Related]
33. SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.
Udhayabanu T; Subramanian VS; Teafatiller T; Gowda VK; Raghavan VS; Varalakshmi P; Said HM; Ashokkumar B
Clin Chim Acta; 2016 Nov; 462():210-214. PubMed ID: 27702554
[TBL] [Abstract][Full Text] [Related]
34. Reversible posterior column dysfunction in Brown-Vialetto-Von Laere syndrome.
Khadilkar SV; Faldu HD; Udani V; Patil SB; Malvadkar S
Muscle Nerve; 2017 Oct; 56(4):E28-E31. PubMed ID: 28543375
[No Abstract] [Full Text] [Related]
35. Brown-Vialetto-Van Laere Syndrome as a Mimic of Neuroimmune Disorders: 3 Cases From the Clinic and Review of the Literature.
Allison T; Roncero I; Forsyth R; Coffman K; Pichon JL
J Child Neurol; 2017 May; 32(6):528-532. PubMed ID: 28116953
[TBL] [Abstract][Full Text] [Related]
36. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency.
O'Callaghan B; Bosch AM; Houlden H
J Inherit Metab Dis; 2019 Jul; 42(4):598-607. PubMed ID: 30793323
[TBL] [Abstract][Full Text] [Related]
37. Brown-Vialetto-Van Laere syndrome: two siblings with a new mutation and dramatic therapeutic effect of high-dose riboflavin.
Horoz OO; Mungan NO; Yildizdas D; Hergüner Ö; Ceylaner S; Kör D; Waterham H; Coskun T
J Pediatr Endocrinol Metab; 2016 Feb; 29(2):227-31. PubMed ID: 26444347
[TBL] [Abstract][Full Text] [Related]
38. Novel riboflavin transporter family RFVT/SLC52: identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52.
Yonezawa A; Inui K
Mol Aspects Med; 2013; 34(2-3):693-701. PubMed ID: 23506902
[TBL] [Abstract][Full Text] [Related]
39. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment.
Bosch AM; Abeling NG; Ijlst L; Knoester H; van der Pol WL; Stroomer AE; Wanders RJ; Visser G; Wijburg FA; Duran M; Waterham HR
J Inherit Metab Dis; 2011 Feb; 34(1):159-64. PubMed ID: 21110228
[TBL] [Abstract][Full Text] [Related]
40. Three cases of adult-onset Brown-Vialetto-Van Laere syndrome: Novel variants in SLC52A3 gene and MRI abnormalities.
Carey G; Kuchcinski G; Gauvrit F; Defebvre L; Nguyen S; Dhaenens CM; Dessein AF; Vianey-Saban C; Acquaviva C; Tard C
Neuromuscul Disord; 2021 Aug; 31(8):752-755. PubMed ID: 34384672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
